HM
AGN.PRA

Howard Marks’s Allergan plc AGN.PRA Stock Holding History

Howard Marks’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25,296
Closed -$18.7M – 210
2017
Q3 		$18.7M Sell
25,296
-45,000
-64% -$37.4M 0.28% 84
2017
Q2 		$61M Buy
+70,296
New +$58.9M 1% 19
2016
Q4 		– Sell
-6,183
Closed -$5.06M – 202
2016
Q3 		$5.06M Sell
6,183
-84,500
-93% -$73M 0.07% 166
2016
Q2 		$83.9M Buy
90,683
+28,783
+46% +$24M 1.51% 11
2016
Q1 		$56.9M Sell
61,900
-32,000
-34% -$30.6M 1.02% 22
2015
Q4 		$96.6M Buy
93,900
+21,900
+30% +$22M 1.28% 14
2015
Q3 		$67.9M Buy
+72,000
New +$75.1M 0.89% 24

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Howard Marks's AGN.PRA Position: Q4 2017 in Review

Howard Marks sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 25,296 shares — an estimated $18.7M sold.

Howard Marks first reported a position in AGN.PRA in Q3 2015 and held it in 7 quarters. The position peaked at $96.6M in Q4 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Howard Marks reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Howard Marks sold 25,296 Allergan plc shares in Q4 2017, an estimated $18.7M.
  • Howard Marks first reported a position in Allergan plc in Q3 2015 and held it in 7 quarters.
  • Howard Marks's Allergan plc position peaked at $96.6M in Q4 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Oaktree Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.